OBJECTIVE: To find out the eefctiveness of JEB Carboplatin, Bleomycin and Etoposide therapy in Pediatric Malignant Germ Cell Tumors post-operatively. STUDY DESIGN: A Observational study. PLACE & DURATION: From 1st December 2009 to 30th December 2016 at Oncology Department, Children Hospital, PIMS. METHODOLOGY: Children diagnosed with malignant germ cell tumor on histopathology and treated with radical excision and JEB (carboplatin, bleomycin and etoposide) regimen were followed for the period of at least one year. Pre-operative, post-operative and post follow up, CT, alpha-fetoprotein levels, beta HCG levels were evaluated. Aeftr each cycle of chemotherapy, CBC, creatinine and ALT levels were checked to assess side eefct profile. RESULTS: The treatment was highly successful (?2 = 49, P-value < 0.00001) with very minimal rate of complications (15%) and adverse eefcts. Mean age of disease was 4.9 + 3.32 years with female predominance. Yolk sac tumor was most common (40%) histological type. No hypersensitivity reaction, renal and hepatic toxicity was reported. No grade IV or V cytopenias were noted. Raised Alpha feto protein levels were noted in 75% of the cases while beta HCG was raised in 20% cases. CONCLUSION: The malignant germ cell tumors in children can be eefctively treated by combination of surgery and JEB regimen (carboplatin, bleomycin and etoposide).